24. Shimoda E, Inoue K, Wakai N, Morimoto Y, Asakawa I, Fujitani N, Yoshimine T, Tamamoto T, Takeda M, Ogawa K, Asada H, Hasegawa M. Feasibility and efficacy of definitive hypofractionated high-dose radiotherapy for cutaneous angiosarcoma of the scalp. Int J Cancer Clin Res 2: on line, 2015

25. Miura S, Ohno Y, Kimura H, Kichikawa K. Quantitative lung perfused blood volume imaging on dual-energy CT: capability for quantitative assessment of disease severity in patients with acute pulmonary thromboembolism. Acta Radiol. 56(3):284-93, 2015

26. Tanaka N, Asakawa I, Hasegawa M, Fujimoto K. Urethral toxicity after LDR brachytherapy: experience in Japan. Brachytherapy. 14(2):131-5, 2015

27. Shimomura H, Sasahira T, Yamanaka Y, Kurihara M, Imai Y, Tamaki S, Yamakawa N, Shirone N, Hasegawa M, Kuniyasu H, Kirita T. [18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma. Int J Clin Oncol. 20(2):308-16, 2015

28. Hayashi K, Isohashi F, Akino Y, Wakai N, Mabuchi S, Suzuki O, Seo Y, Ootani Y, Sumida I, Yoshioka Y, Kimura T, Ogawa K. Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method. J Radiat Res. 56(3):546-52, 2015

29. Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, Tamamoto T, Nishiofuku H, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y. Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer. Langenbecks Arch Surg. 400(4):477-85, 2015

30. Wakai N, Sumida I, Otani Y, Suzuki O, Seo Y, Isohashi F, Yoshioka Y, Hasegawa M, Ogawa K. Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam. Med Phys. 42(5):2125-31, 2015

31. Himuro Y, Miyagawa F, Fukumoto T, Morii T, Hasegawa M, Kobayashi N, Asada H. Hypersensitivity to influenza vaccine in a case of Epstein-Barr virus-associated T-lymphoproliferative disorder. Br J Dermatol. 172(6):1686-1688, 2015

32. Miyake M, Tanaka N, Asakawa I, Tatsumi Y, Nakai Y, Anai S, Torimoto K, Aoki K, Yoneda T, Hasegawa M, Konishi N, Fujimoto K. Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer. Radiother Oncol. 115(3):321-6, 2015

33. Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y. Importance of resectability status in neoadjuvant treatment for pancreatic cancer. J Hepatobiliary Pancreat Sci. 22(7):563-70, 2015

34. Akahori T, Sho M, Kinoshita S, Nagai M, Nishiwada S, Tanaka T, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y. Prognostic Significance of Muscle Attenuation in Pancreatic Cancer Patients Treated with Neoadjuvant Chemoradiotherapy. World J Surg. 39(12):2975-82, 2015